Cargando…

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine

Lipid nanoparticle (LNP)-formulated nucleoside-modified mRNA vaccines have proven to be very successful in the fight against the coronavirus disease 2019 (COVID-19) pandemic. They are effective, safe, and can be produced in large quantities. However, the long-term storage of mRNA-LNP vaccines withou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muramatsu, Hiromi, Lam, Kieu, Bajusz, Csaba, Laczkó, Dorottya, Karikó, Katalin, Schreiner, Petra, Martin, Alan, Lutwyche, Peter, Heyes, James, Pardi, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815268/ https://www.ncbi.nlm.nih.gov/pubmed/35131437 http://dx.doi.org/10.1016/j.ymthe.2022.02.001

Ejemplares similares

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
por: Karikó, Katalin, et al.
Publicado: (2011)

ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
por: Daly, Owen, et al.
Publicado: (2023)

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
por: Pardi, Norbert, et al.
Publicado: (2022)

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
por: Pardi, Norbert, et al.
Publicado: (2019)

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
por: Pardi, Norbert, et al.
Publicado: (2017)

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
por: McMahon, Meagan, et al.
Publicado: (2022)

Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L
por: Anderson, Bart R., et al.
Publicado: (2011)

Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
por: Karikó, Katalin, et al.
Publicado: (2012)

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
por: Pardi, Norbert, et al.
Publicado: (2018)

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
por: Szőke, Dániel, et al.
Publicado: (2021)

Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
por: Freyn, Alec W., et al.
Publicado: (2021)

A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
por: Baiersdörfer, Markus, et al.
Publicado: (2019)

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
por: Laczkó, Dorottya, et al.
Publicado: (2020)

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
por: Tombácz, István, et al.
Publicado: (2021)

Zika virus protection by a single low dose nucleoside modified mRNA vaccination
por: Pardi, Norbert, et al.
Publicado: (2017)

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
por: Anderson, Bart R., et al.
Publicado: (2010)

A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
por: Nir, Ronit, et al.
Publicado: (2022)

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
por: Pardi, Norbert, et al.
Publicado: (2018)

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
por: Carreño, Juan Manuel, et al.
Publicado: (2022)

Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
por: Franzé, Silvia, et al.
Publicado: (2018)

Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters
por: Degobert, Ghania, et al.
Publicado: (2021)

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
por: Alameh, Mohamad-Gabriel, et al.
Publicado: (2022)

Rational design of heat stable lyophilized rotavirus vaccine formulations
por: Madan, Madhu, et al.
Publicado: (2018)

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
por: Alameh, Mohamad-Gabriel, et al.
Publicado: (2021)

Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
por: Boros, Gábor, et al.
Publicado: (2015)

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury
por: Gál, László, et al.
Publicado: (2023)

Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation
por: Robbie, Gabriel J., et al.
Publicado: (2014)

Development of a Lyophilized Formulation of Pegaspargase and Comparability Versus Liquid Pegaspargase
por: Faschinger, Alexander M., et al.
Publicado: (2019)

What does the success of mRNA vaccines tell us about the future of biological therapeutics?
por: Karikó, Katalin, et al.
Publicado: (2021)

mRNA Innovates the Vaccine Field
por: Pardi, Norbert
Publicado: (2021)

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
por: Rizvi, Fatima, et al.
Publicado: (2021)

Nucleoside-Modified mRNA Vaccines Protect IFNAR(–/–) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
por: Appelberg, Sofia, et al.
Publicado: (2022)

The Influence of Formulation and Manufacturing Process Parameters on the Characteristics of Lyophilized Orally Disintegrating Tablets
por: Jones, Rhys J., et al.
Publicado: (2011)

Detection of Collapse and Crystallization of Saccharide, Protein, and Mannitol Formulations by Optical Fibers in Lyophilization
por: Horn, Jacqueline, et al.
Publicado: (2018)

Lyophilized Drug-Loaded Solid Lipid Nanoparticles Formulated with Beeswax and Theobroma Oil
por: Amekyeh, Hilda, et al.
Publicado: (2021)

Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations
por: Szente, Lajos, et al.
Publicado: (2021)

Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticles
por: Mu, Zekun, et al.
Publicado: (2021)

Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
por: Rizvi, Fatima, et al.
Publicado: (2021)

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
por: Foster, Jessica B., et al.
Publicado: (2019)

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
por: LaTourette, Philip C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qi64qtvtbnnv74o15fnubgqrvd